Shopping Cart
- Remove All
Your shopping cart is currently empty
Androgen receptor antagonist 4 (Compound AT2) exhibits anticancer activities by potently antagonizing AR transcriptional activity, inhibiting downstream AR target genes, and blocking DHT-induced nuclear translocation of AR. It is an antagonist of the androgen receptor (AR) with an IC50 of 0.15 μM [1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,140 | 6-8 weeks | |
| 50 mg | $2,785 | 6-8 weeks | |
| 100 mg | $3,520 | 6-8 weeks |
| Description | Androgen receptor antagonist 4 (Compound AT2) exhibits anticancer activities by potently antagonizing AR transcriptional activity, inhibiting downstream AR target genes, and blocking DHT-induced nuclear translocation of AR. It is an antagonist of the androgen receptor (AR) with an IC50 of 0.15 μM [1]. |
| Molecular Weight | 331.84 |
| Formula | C22H18ClN |
| Cas No. | 354815-43-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.